Excess breast cancer risk in first degree relatives of CHEK2* 1100delC positive familial breast cancer cases

European Journal of Cancer

Volumn 49, Issue 8, 2013, Pages 1993-1999

  Adank, Muriel A ^a   Verhoef, Senno ^b   Oldenburg, Rogier A ^c   Schmidt, Marjanka K ^b   Hooning, Maartje J ^d   Martens, John W M ^c   Broeks, Annegien ^b   Rookus, Matti ^b   Waisfisz, Quinten ^a   Witte, Birgit I ^e   Jonker, Marianne A ^f   Meijers Heijboer, Hanne ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Breast cancer; Cancer incidence; CHEK2; CHEK2*1100delC; Familial; Relatives

Indexed keywords

CHECKPOINT KINASE 2;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; FIRST DEGREE RELATIVE; GENE MUTATION; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FAMILY; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MUTATION; PEDIGREE; PROTEIN-SERINE-THREONINE KINASES; RISK FACTORS; SEQUENCE DELETION; SIBLINGS;

EID: 84876683067     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.01.009     Document Type: Article

References (22)

1. H. Meijers-Heijboer, A. van den Ouweland, and J. Klijn Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations Nat Genet 31 2002 55 59
2. L. Antoni, N. Sodha, I. Collins, and M.D. Garrett CHK2 kinase: cancer susceptibility and cancer therapy-two sides of the same coin? Nat Rev Cancer 7 2007 925 936
3. The CHEK2 breast cancer case-control consortium CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9065 controls from 10 studies Am J Hum Genet 74 2004 1175 1182
4. S.A. Narod Testing for CHEK2 in the cancer genetics clinic: ready for prime time? Clin Genet 78 2010 1 7
5. O. Fletcher, N. Johnson, and I. Dos Santos Silva Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2*1100delC in 1828 bilateral breast cancers and 7030 controls Cancer Epidemiol Biomarkers Prev 18 2009 230 234
6. M. Weischer, S.E. Bojesen, C. Ellervik, A. Tybjaerg-Hansen, and D.G. Nordestgaard CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls J Clin Oncol 26 2008 542 548
7. C. Cybulski, D. Wokolorczyk, and A. Jakubowska Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer J Clin Oncol 29 2011 3747 3752
8. P.D.P. Pharoah, A. Antoniou, M. Bobrow, R.L. Zimmern, D.F. Easton, and B.A.J. Ponder Polygenic susceptibility to breast cancer and implications for prevention Nat Genet 31 2002 33 36
9. R.A. Oldenburg, K. Kroeze-Jansema, and J. Kraan The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/2 multiple-case families Cancer Res 63 2003 8153 8157
10. Collaborative Group on Hormonal Factors in Breast Cancer Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease Lancet 358 2001 1389 1399
11. K. Offit, and J.E. Garber Time to check CHEK2 in families with breast cancer? J Clin Oncol 26 2008 519 520
12. M. Robson CHEK2, breast cancer, and the understanding of clinical utility Clin Genet 78 2010 8 10
13. M.A. Adank, M.A. Jonker, and I. Kluijt CHEK2*1100delC homozygosity is associated with a high breast cancer risk in women J Med Genet 48 2011 860 863
14. J. Gronwald, C. Cybulski, and W. Piesiak Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband Br J Cancer 100 2009 1508 1512
15. M. Wasielewski, H. Vasen, and J. Wijnen CHEK2 1100delC is a susceptibility allele for HNPCC-related colorectal cancer Clin Cancer Res 14 2008 4989 4994
16. H.P. Xiang, X.P. Geng, W.W. Ge, and H. Li Meta-analysis of CHEK2 1100delC variant and colorectal cancer susceptibility Eur J Cancer 47 2011 2546 2551
17. M. Bevier, K. Sundquist, and K. Hemminki Risk of breast cancer in families of multiple affected women and men Breast Cancer Res Treat 132 2011 723 728
18. N. Johnson, O. Fletcher, C. Naceur-Lombardelli, I. Dos Santos Silva, A. Ashworth, and J. Peto Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes: a familial study Lancet 366 2005 1554 1557
19. A. Broeks, L. de Witte, and A. Nooijen Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers Breast Cancer Res Treat 83 2004 91 93
20. L. Mellemkjaer, C. Dahl, and J.H. Olsen Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study Br J Cancer 98 2008 728 733
21. D.G. Evans, M. Ahmed, S. Bayliss, E. Howard, F. Lalloo, and A. Wallace BRCA1, BRCA2 and CHEK2 c.1100 delC mutations in patients with double primaries of the breasts and/or ovaries J Med Genet 47 2010 561 566
22. D. Thompson, S. Seal, and M. Schutte A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers Cancer Epidemiol Biomarkers Prev 15 2006 2542 2545